KOSPI · Healthcare · ₩336B
₩34,850+2.80%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
Preliminary · some items pending
6/'26 vs prev quarter
Short Volume 3.3% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기 매출이 늘고 손익도 다시 플러스로 돌아섰어요.”
In the company's words · 2026 2분기 filing